June 6, 2024
NOT-DK-24-025 - Notice of Expiration for NIDDK's NOT-DK-24-010 Notice of Special Interest (NOSI): "Administrative Supplements to Enhance Engagement Activity with Underserved Populations Within the Type 1 Diabetes Community (Admin Supp Clinical Trial Not Allowed)"
PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.
Sexual and Gender Minority Research Office (SGMRO)
Purpose
NIDDK aims to achieve equitable engagement in research across all persons impacted by type 1 diabetes (T1D). Understanding that participation in research is inequitable across many groups impacted by T1D, this supplement opportunity supports activities which enhance outreach to and engagement with underserved populations which experience diabetes-related health disparities. (ref. NIH designated health disparities populations). Improved engagement, participation, and incorporation of leadership from underserved T1D populations is deemed essential for addressing disparities and advancing health equity in T1D outcomes.
This supplement opportunity is available to PD(s)/PI(s) of active NIDDK research grants investigating T1D. Administrative supplements must support work within the scope of the original project and cannot be used to support planning activities for future grants.
Background
The NIDDKs Strategic Plan highlights the cross-cutting theme of achieving health equity by eliminating health disparities among racial and ethnic minority populations and others who are underserved. T1D is one mission disease with significant disparities. Approximately 2 million Americans live with T1D and individuals with less socioeconomic support and those from underserved rural and/or racial and ethnic populations have worse glycemic control, increased complications, and worse quality of life compared to non-minoritized individuals. To address these health disparities, it is paramount that research studies have equitable engagement and participation across all interested parties. Community-engaged research brings to bear the lived experience and expertise of the affected communities, which may yield interventions that are more likely to be appropriate, acceptable, and feasible, and less likely to cause harm. Community engagement that involves trust building, use of culturally appropriate research designs, questions, and materials (i.e., outreach, recruitment, retention, informed consents) is an important method to enhance and assess research outcomes including participation goals, health specific outcomes and sustainability. To this end, NIDDK aims to achieve equitable engagement with a broad array of individuals (including people from NIH designated health disparities populations) in T1D research; particularly those from communities that experience diabetes-related health disparities. Understanding that participation in research is inequitable across many groups impacted by T1D, this supplement opportunity offers support for enhancing engagement with underserved populations.
Research Objectives
Administrative Supplements will support 1 to 2 years of activities which are deemed necessary to strengthen engagement and participation with health disparities communities affected by T1D to enhance the success of the parent project. The purpose of the supplemental activity is to provide additional resources to investigators with active NIDDK T1D human subject research who are not successfully engaging with or recruiting/retaining health disparities populations into the ongoing research study, despite initial engagement efforts. With additional budgetary resources, supplemental activity should strengthen relationships between clinical and/or basic T1D investigators and individuals living with T1D, related care givers, and/or other community and advocate persons with interest in T1D outcomes with the goal of enhancing the deliverables of the active research project. The engagement activities must aim to improve participation from and community relationships with individuals from NIH designated health disparities populations. Active and meaningful engagement should involve these individuals and/or organizations in the development, design, and execution of the study, as well as in dissemination of findings. Given that these are supplements to existing studies, the activities proposed will vary based on the stage of the study and must be within scope of the parent research projects initial engagement activity such as approaches for recruitment, retention, or intervention feedback. Also, supported, meaningful engagement must entail more than focus groups, surveys, or other activities where people are only involved as participants or respondents. Rather, engagement approaches must involve bidirectional and sustained communication and interactions that result in informed decision-making about the research activities.
Supported specific activities will include, but are not limited to, the following:
Budget Information
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
All instructions in the SF424 (R&R) Application Guide and PA-20-272 must be followed, with the following additions:
Please direct all inquiries to:
Miranda M. Broadney MD, MPH
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone:301-594-1176
Email: Miranda.Broadney@nih.gov